Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ImaginAb closes $12.5mm Series A round

Executive Summary

ImaginAb Inc. (developing in vivo imaging agents for cancer and autoimmune diseases) has raised $12.5mm in its oversubscribed Series A financing led by Novartis Venture Funds, which was joined by Merieux Developpement, Nextech Invest, Cycad Group, an undisclosed backer, and returning seed investor Momentum Biosciences. Representatives from Novartis Venture Funds and Merieux Developpement will join the board.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register